Eva-Maria Collnot

2.3k total citations
16 papers, 1.9k citations indexed

About

Eva-Maria Collnot is a scholar working on Genetics, Pharmaceutical Science and Oncology. According to data from OpenAlex, Eva-Maria Collnot has authored 16 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 4 papers in Pharmaceutical Science and 4 papers in Oncology. Recurrent topics in Eva-Maria Collnot's work include Inflammatory Bowel Disease (6 papers), Drug Transport and Resistance Mechanisms (4 papers) and Microscopic Colitis (4 papers). Eva-Maria Collnot is often cited by papers focused on Inflammatory Bowel Disease (6 papers), Drug Transport and Resistance Mechanisms (4 papers) and Microscopic Colitis (4 papers). Eva-Maria Collnot collaborates with scholars based in Germany, United States and United Kingdom. Eva-Maria Collnot's co-authors include Claus‐Michael Lehr, Christiane Baldes, Hussain Ali, Michael F. Wempe, Ulrich F. Schaefer, Kevin J. Edgar, Fransisca Leonard, John A. Hyatt, Eric Fabian and Dejan Djurić and has published in prestigious journals such as Journal of Controlled Release, Sensors and Actuators B Chemical and Pharmaceutical Research.

In The Last Decade

Eva-Maria Collnot

16 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eva-Maria Collnot Germany	14	665	478	423	325	281	16	1.9k
Jaber Emami Iran	29	922 1.4×	643 1.3×	713 1.7×	180 0.6×	341 1.2×	80	2.5k
Hibah M. Aldawsari Saudi Arabia	28	633 1.0×	404 0.8×	864 2.0×	242 0.7×	304 1.1×	84	2.4k
Kaushik Thanki India	30	1.0k 1.6×	784 1.6×	936 2.2×	236 0.7×	268 1.0×	56	2.6k
Ana Beloqui Belgium	29	1.5k 2.2×	599 1.3×	1.0k 2.4×	152 0.5×	268 1.0×	58	3.0k
Gian Paolo Zara Italy	27	1.1k 1.6×	596 1.2×	1.0k 2.4×	253 0.8×	309 1.1×	46	2.4k
Young Wook Choi South Korea	33	1.5k 2.2×	529 1.1×	894 2.1×	178 0.5×	324 1.2×	133	3.1k
Ling Zhao China	32	384 0.6×	659 1.4×	1.0k 2.4×	340 1.0×	472 1.7×	95	2.7k
Padma V. Devarajan India	31	857 1.3×	929 1.9×	1.0k 2.4×	208 0.6×	462 1.6×	91	3.0k
Bizhan Malaekeh‐Nikouei Iran	30	523 0.8×	724 1.5×	1.2k 2.8×	278 0.9×	518 1.8×	116	2.8k
Soo‐Jeong Lim South Korea	34	1.4k 2.1×	746 1.6×	1.3k 3.1×	323 1.0×	394 1.4×	88	3.4k

Countries citing papers authored by Eva-Maria Collnot

Since Specialization

Citations

This map shows the geographic impact of Eva-Maria Collnot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva-Maria Collnot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva-Maria Collnot more than expected).

Fields of papers citing papers by Eva-Maria Collnot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva-Maria Collnot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva-Maria Collnot. The network helps show where Eva-Maria Collnot may publish in the future.

Co-authorship network of co-authors of Eva-Maria Collnot

This figure shows the co-authorship network connecting the top 25 collaborators of Eva-Maria Collnot. A scholar is included among the top collaborators of Eva-Maria Collnot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva-Maria Collnot. Eva-Maria Collnot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Leonard, Fransisca, Srimeenakshi Srinivasan, Xuewu Liu, et al.. (2020). Design and in vitro characterization of multistage silicon-PLGA budesonide particles for inflammatory bowel disease. European Journal of Pharmaceutics and Biopharmaceutics. 151. 61–72. 21 indexed citations

Ali, Hussain, Benno Weigmann, Eva-Maria Collnot, et al.. (2015). Budesonide Loaded PLGA Nanoparticles for Targeting the Inflamed Intestinal Mucosa—Pharmaceutical Characterization and Fluorescence Imaging. Pharmaceutical Research. 33(5). 1085–1092. 69 indexed citations

Crécy, F. de, et al.. (2015). A Design of Experiment Study of Nanoprecipitation and Nano Spray Drying as Processes to Prepare PLGA Nano- and Microparticles with Defined Sizes and Size Distributions. Pharmaceutical Research. 32(8). 2609–24. 46 indexed citations

Carvalho‐Wodarz, Cristiane de Souza, Urška Repnik, Eva-Maria Collnot, et al.. (2015). A 3D co-culture of three human cell lines to model the inflamed intestinal mucosa for safety testing of nanomaterials. Nanotoxicology. 10(1). 1–10. 82 indexed citations

Ucciferri, Nadia, M. Favre, Eva-Maria Collnot, et al.. (2015). Dual flow bioreactor with ultrathin microporous TEER sensing membrane for evaluation of nanoparticle toxicity. Sensors and Actuators B Chemical. 223. 440–446. 8 indexed citations

Lefebvre, David E., Koen Venema, Lourdes Gombau, et al.. (2014). Utility of models of the gastrointestinal tract for assessment of the digestion and absorption of engineered nanomaterials released from food matrices. Nanotoxicology. 9(4). 523–542. 84 indexed citations

Ali, Hussain, Eva-Maria Collnot, Maike Windbergs, & Claus‐Michael Lehr. (2013). Nanomedicines for the treatment of inflammatory bowel diseases. HZI Open Repository (Helmholtz-Zentrum für Infektionsforschung GmbH). 5(1). 23–38. 8 indexed citations

Bessems, Jos, George Loizou, Kannan Krishnan, et al.. (2013). PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment. Regulatory Toxicology and Pharmacology. 68(1). 119–139. 109 indexed citations

Collnot, Eva-Maria, Hussain Ali, & Claus‐Michael Lehr. (2012). Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosa. Journal of Controlled Release. 161(2). 235–246. 212 indexed citations

10.

Schmidt, Carsten, Eva-Maria Collnot, Michael Schümann, et al.. (2012). Nano- and microscaled particles for drug targeting to inflamed intestinal mucosa—A first in vivo study in human patients. Journal of Controlled Release. 165(2). 139–145. 189 indexed citations

11.

Linn, Michael, Eva-Maria Collnot, Dejan Djurić, et al.. (2011). Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo. European Journal of Pharmaceutical Sciences. 45(3). 336–343. 212 indexed citations

12.

Collnot, Eva-Maria, Christiane Baldes, Ulrich F. Schaefer, et al.. (2010). Vitamin E TPGS P-Glycoprotein Inhibition Mechanism: Influence on Conformational Flexibility, Intracellular ATP Levels, and Role of Time and Site of Access. Molecular Pharmaceutics. 7(3). 642–651. 190 indexed citations

13.

Leonard, Fransisca, Eva-Maria Collnot, & Claus‐Michael Lehr. (2010). A Three-Dimensional Coculture of Enterocytes, Monocytes and Dendritic Cells To Model Inflamed Intestinal Mucosa in Vitro. Molecular Pharmaceutics. 7(6). 2103–2119. 175 indexed citations

14.

Collnot, Eva-Maria, Christiane Baldes, Michael F. Wempe, et al.. (2007). Mechanism of Inhibition of P-Glycoprotein Mediated Efflux by Vitamin E TPGS: Influence on ATPase Activity and Membrane Fluidity. Molecular Pharmaceutics. 4(3). 465–474. 244 indexed citations

15.

Collnot, Eva-Maria, Christiane Baldes, Michael F. Wempe, et al.. (2006). Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers. Journal of Controlled Release. 111(1-2). 35–40. 154 indexed citations

16.

Ehrhardt, Carsten, Eva-Maria Collnot, Christiane Baldes, et al.. (2005). Towards an in vitro model of cystic fibrosis small airway epithelium: characterisation of the human bronchial epithelial cell line CFBE41o-. Cell and Tissue Research. 323(3). 405–415. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact